Deletions and point mutations of the growth hormone (GH) receptor gene
(GHR) have been identified in patients with Laron syndrome. We report
the first detection of the GHR mutation among Japanese patients with
Laron syndrome. Using the Japanese female patient's genomic DNA as a t
emplate, all exons and flanking portions of introns of GHR were amplif
ied by polymerase chain reaction (PCR). Sequencing of the PCR products
showed that the patient was homozygous for a G to A substitution at t
he first position of intron 4. This substitution was same as that dete
cted in a Spanish patient and a north European patient. The base chang
e occurred at the 5' splice consensus sequence of intron 4, resulting
in the abolition of a BanI restriction site. Since this substitution w
as not detected by a BanI restriction analysis in 85 control individua
ls, it is more likely a disease-related splice mutation than a polymor
phism. The mutation in our patient was predicted to destroy the origin
al 5' splice site of intron 4 of GHR and to produce a new cryptic spli
ce site, leading to abnormal mRNA processing and a lack of GH binding
activity of GH-binding protein (GHBP).